A Review of SARS-CoV-2 and the Ongoing Clinical Trials

The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) in Wuhan, China, which rapidly grew into a global pandemic, marked the third introduction of a virulent coronavirus into the human society, affecting not only the healthcare system, but also the global economy. Althoug...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2020-04, Vol.21 (7), p.2657
Hauptverfasser:	Tu, Yung-Fang, Chien, Chian-Shiu, Yarmishyn, Aliaksandr A, Lin, Yi-Ying, Luo, Yung-Hung, Lin, Yi-Tsung, Lai, Wei-Yi, Yang, De-Ming, Chou, Shih-Jie, Yang, Yi-Ping, Wang, Mong-Lien, Chiou, Shih-Hwa
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Antiviral Agents - therapeutic use Betacoronavirus - chemistry Betacoronavirus - genetics Betacoronavirus - immunology Betacoronavirus - physiology Chemical compounds Clinical trials Clinical Trials as Topic Coronaviridae Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronavirus Infections - prevention & control Coronavirus Infections - therapy Coronavirus Infections - virology Coronaviruses COVID-19 COVID-19 Drug Treatment COVID-19 Serotherapy COVID-19 Vaccines Drug development Epidemiology Fatalities Genome, Viral Genomes Global economy Humans Hydroxychloroquine Immune response Immunization, Passive Immunologic Factors - therapeutic use Immunosuppressive agents Immunotherapy Inflammation Middle East respiratory syndrome Outbreaks Pandemics Pharmacology Pneumonia, Viral - diagnosis Pneumonia, Viral - epidemiology Pneumonia, Viral - therapy Pneumonia, Viral - virology Replication Respiratory diseases Review Reviews SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vaccines Viral Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!